LSTM Home > LSTM Research > LSTM Online Archive

Molecular mechanisms of re-emerging chloramphenicol susceptibility in extended-spectrum beta-lactamase-producing Enterobacterales

Graf, Fabrice ORCID: https://orcid.org/0000-0003-1132-5348, Goodman, Richard, Gallichan, Sarah, Forrest, Sally, Picton-Barlow, Esther, Fraser, Alice, Phan, Minh-Duy, Mphasa, Madalitso, Hubbard, Alasdair ORCID: https://orcid.org/0000-0001-6668-9179, Musicha, Patrick, Schembri, Mark A., Roberts, Adam ORCID: https://orcid.org/0000-0002-0760-3088, Edwards, Thomas, Lewis, Joseph ORCID: https://orcid.org/0000-0002-3837-5188 and Feasey, Nicholas ORCID: https://orcid.org/0000-0003-4041-1405 (2024) 'Molecular mechanisms of re-emerging chloramphenicol susceptibility in extended-spectrum beta-lactamase-producing Enterobacterales'. Nature Communications, Vol 15, Issue 1, e9019.

[img]
Preview
Text
41467_2024_Article_53391.pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Infections with Enterobacterales (E) are increasingly difficult to treat due to antimicrobial resistance. After ceftriaxone replaced chloramphenicol (CHL) as empiric therapy for suspected sepsis in Malawi in 2004, extended-spectrum beta-lactamase (ESBL)-E rapidly emerged. Concurrently, resistance to CHL in Escherichia coli and Klebsiella spp. decreased, raising the possibility of CHL re-introduction. However, many phenotypically susceptible isolates still carry CHL acetyltransferase (cat) genes. To understand the molecular mechanisms and stability of this re-emerging CHL susceptibility we use a combination of genomics, phenotypic susceptibility assays, experimental evolution, and functional assays for CAT activity. Here, we show that of 840 Malawian E. coli and Klebsiella spp. isolates, 31% have discordant CHL susceptibility genotype–phenotype, and we select a subset of 42 isolates for in-depth analysis. Stable degradation of cat genes by insertion sequences leads to re-emergence of CHL susceptibility. Our study suggests that CHL could be reintroduced as a reserve agent for critically ill patients with ESBL-E infections in Malawi and similar settings and highlights the ongoing challenges in inferring antimicrobial resistance from sequence data.

Item Type: Article
Subjects: QV Pharmacology > Anti-Bacterial Agents. Tissue Extracts > QV 350.5.C5 Chloramphenicol
WC Communicable Diseases > Infection. Bacterial Infections > Enteric Infections > WC 290 Escherichia coli infections
Faculty: Department: Biological Sciences > Department of Tropical Disease Biology
Biological Sciences > Vector Biology Department
Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI): https://doi.org/10.1038/s41467-024-53391-2
SWORD Depositor: JISC Pubrouter
Depositing User: JISC Pubrouter
Date Deposited: 06 Nov 2024 12:08
Last Modified: 06 Nov 2024 12:08
URI: https://archive.lstmed.ac.uk/id/eprint/25486

Statistics

View details

Actions (login required)

Edit Item Edit Item